Iron Metabolism in Small Pre Term Newborns
1 other identifier
interventional
50
1 country
1
Brief Summary
Iron is an essential micronutrient that plays an important role in cellular functions of all microorganisms. Both iron deficiency and iron excess during the early weeks of life can have severe effects on neurodevelopment that may persist into adulthood and may not be corrected by restoration of normal iron levels. Iron overload remains a significant concern in preterm infants because they have low levels of iron-binding proteins and immature antioxidant systems. The aim of the study is to evaluate if iron supplementation is required/necessary in VLBW Very Low Birth Weight (less than 1500 grams) and to assess the efficacy and safety of the iron supplementation practice for VLBW preterm infants as implemented in the Neonatal Intensive Care Unit (NICU) at the Ha'Emek Medical Center, Afula, Israel.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Oct 2011
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 27, 2011
CompletedFirst Posted
Study publicly available on registry
September 29, 2011
CompletedStudy Start
First participant enrolled
October 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2020
CompletedNovember 1, 2019
October 1, 2019
9.3 years
September 27, 2011
October 30, 2019
Conditions
Outcome Measures
Primary Outcomes (1)
Assessment of iron status in preterm infants and identify which preterm infants are at risk for iron deficiency or iron overload.
Assessment of the iron status in preterm infants and correlated them with clinical parameters: the blood transfusions given and the amount of blood obtained for routine laboratory analysis, and amount of daily iron intake through diet (human milk or formula)and identify which preterm infants are at risk for iron deficiency or iron overload.
One year
Study Arms (1)
Iron suplementation
EXPERIMENTALIron supplementation with IPC in a dose of 4 mg/kg/day of elemental iron started not before 4 weeks of age and as soon as 120 ml/kg/day of enteral feedings is tolerated given together with the first morning meal
Interventions
Iron supplementation with IPC in a dose of 4 mg/kg/day of elemental iron started not before 4 weeks of age and as soon as 120 ml/kg/day of enteral feedings is tolerated given together with the first morning meal. Serum samples will be obtained at 3 different times: 1. Before starting iron supplementation (maximum one week before). 2. At the beginning of iron supplementation in order to assess early signs of erythropoiesis, iron overload or free iron (day 4 - 7 days of supplementation). 3. Before discharge from hospitalization in order to asses the iron metabolism and sings of iron deficiency (At least more than 2 weeks of supplementation).
Eligibility Criteria
You may qualify if:
- Very Low Birth Weight and / or borne at 30 weeks or less of gestational age that are scheduled to receive enteral iron supplementation as part of the standard protocol currently used by the Neonatal Intensive Care Unit.
You may not qualify if:
- Major physical anomalies,
- renal or cardiac diseases,
- newborns that underwent major surgery during the study period,
- acute or chronic fetal blood loss,
- hemolytic anemia,
- refusal to receive parental consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Pediatric Hematology Unit and Pediatric Dpt B - HaEmek Medical Center
Afula, 18101, Israel
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Head of Pediatric Dpt B and Pediatric Hematology Unit
Study Record Dates
First Submitted
September 27, 2011
First Posted
September 29, 2011
Study Start
October 1, 2011
Primary Completion
December 31, 2020
Study Completion
December 31, 2020
Last Updated
November 1, 2019
Record last verified: 2019-10